Literature DB >> 9493487

Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ).

A H Clayton1, E L McGarvey, G J Clavet, L Piazza.   

Abstract

The Changes in Sexual Functioning Questionnaire (CSFQ), a structured interview/questionnaire designed to measure illness- and medication-related effects on sexual functioning, is presented with initial evidence of its clinical usefulness in differentiating between those who have sexual dysfunction and those who have no dysfunction. Individuals from clinical and nonclinical samples completed the CSFQ. The sample groups were compared on mean scores on the CSFQ and its subscales. Comparative findings indicate that psychiatric patients diagnosed with a mood disorder have significantly lower sexual functioning when compared with nonpsychiatric outpatients, medical students, and psychiatry residents combined. The CSFQ is a useful measure for assessing medication- or illness-related effects on sexual functioning in a systematic way.

Entities:  

Mesh：

Year:  1997        PMID： 9493487

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


  17 in total

Review 1.  Addressing sexual dysfunction in colorectal cancer survivorship care.

Authors:  Jennifer C Averyt; Patricia W Nishimoto
Journal:  J Gastrointest Oncol       Date:  2014-10

Review 2.  A biopsychosocial approach to women's sexual function and dysfunction at midlife: A narrative review.

Authors:  Holly N Thomas; Rebecca C Thurston
Journal:  Maturitas       Date:  2016-02-21       Impact factor: 4.342

3.  Sexual function in women with polycystic ovary syndrome.

Authors:  Dale W Stovall; Jessica L Scriver; Anita H Clayton; Christopher D Williams; Lisa M Pastore
Journal:  J Sex Med       Date:  2011-11-14       Impact factor: 3.802

4.  Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Authors:  Marcio Versiani; Ricardo Moreno; Catharina J A Ramakers-van Moorsel; Albert J Schutte
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.

Authors:  Teresa Lanza di Scalea; Barbara H Hanusa; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2009-03-09       Impact factor: 4.384

6.  The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives.

Authors:  Jeffrey R Bishop; Vicki L Ellingrod; Michael Akroush; Jessica Moline
Journal:  Hum Psychopharmacol       Date:  2009-04       Impact factor: 1.672

Review 7.  Female sexual dysfunction.

Authors:  Erdogan Aslan; Michelle Fynes
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-01

8.  Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study.

Authors:  Carl Gommoll; Giovanna Forero; Maju Mathews; Rene Nunez; Xiongwen Tang; Suresh Durgam; Angelo Sambunaris
Journal:  Int Clin Psychopharmacol       Date:  2015-11       Impact factor: 1.659

9.  Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.

Authors:  Anita H Clayton; Carl Gommoll; Dalei Chen; Rene Nunez; Maju Mathews
Journal:  Int Clin Psychopharmacol       Date:  2015-07       Impact factor: 1.659

10.  A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.

Authors:  Carl Gommoll; Suresh Durgam; Maju Mathews; Giovanna Forero; Rene Nunez; Xiongwen Tang; Michael E Thase
Journal:  Depress Anxiety       Date:  2015-04-17       Impact factor: 6.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.